Tibion Corporation, a leading developer of bionic technologies for the mobility impaired, announced that it has engaged in a collaboration with Stanford University’s Biomechanical Engineering Group to develop future applications of its bionic technology. Per the agreement, a team of Stanford graduate students will be working to extend Tibion’s technology platform to additional medical applications. The work will serve as a foundation for future development activities to address mobility impairment across a wide range of acute and chronic indications.
Tom Andriacchi, Ph.D., Chairman of Stanford’s Biomechanical Engineering Group and Professor, Orthopaedic Surgery, stated that “the industry collaboration with Tibion has generated much excitement because of the technology’s capacity to improve the quality of life for many people.” The Stanford team will build on the bionic technology platform provided by Tibion to achieve enhanced mobility for patients suffering from neuromuscular or musculoskeletal pathologies.
Kern Bhugra, Tibion CEO, added, “We are fortunate to have the biomechanical expertise of Tom Andriacchi and his graduate students focused on additional applications of Tibion’s bionic technology and are enthusiastic about the innovative potential.”
A summary and poster session of the collaborative work will be on display during the Biomechanical Engineering and BioDesign Innovation Distinguished Lecture Program to be held on May 27th, 2008, from 2:30-7pm at the Clark Center Auditorium on the Stanford campus.
Tibion develops bionic devices for those with loss of muscle function due to disease, injury, aging, or surgery. Tibion’s products provide exo-skeleton assistance, resistance, and rehabilitation of muscle function via a combination of patented, sensor-driven, actuator technologies, as well as advances in embedded computer systems and orthotic science. Tibion’s initial product is designed to actively assist knee function. Tibion is located at NASA Research Park, Moffett Field, CA.